664 related articles for article (PubMed ID: 35844124)
1. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
2. Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.
Li JB; Ke KJ; Zhang WL; Wang LY; Wu YP; Weng F; Tian H; Qiu ZY; Li Y; Lin SY; Ye MX; Ou QJ; Gong CH; Lu ZH; Pan ZZ; Wan DS; Peng JH; Fang YJ
Cancer Med; 2022 Nov; 11(22):4321-4331. PubMed ID: 35441812
[TBL] [Abstract][Full Text] [Related]
3. Asia-Pacific Colorectal Screening Score Combined With Stool DNA Test Improves the Detection Rate for Colorectal Advanced Neoplasms.
Xu J; Rong L; Gu F; You P; Ding H; Zhai H; Wang B; Li Y; Ma X; Yin F; Yang L; He Y; Sheng J; Jin P
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1627-1636.e4. PubMed ID: 36113828
[TBL] [Abstract][Full Text] [Related]
4. Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China.
Zhang M; Zhang Y; Zhang W; Zhao L; Jing H; Wu X; Guo L; Zhang H; Zhang Y; Zhu S; Zhang S; Zhang X
Cancer Med; 2023 May; 12(10):11816-11827. PubMed ID: 36951442
[TBL] [Abstract][Full Text] [Related]
5. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
[TBL] [Abstract][Full Text] [Related]
6. [Participation rate and detection of colorectal neoplasms based on multi-round fecal immunochemical testing for colorectal cancer screening in the Chinese population].
Li N; Zhou YY; Lu M; Zhang YH; Lu B; Luo CY; Luo JH; Cai J; Chen HD; Dai M
Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1041-1050. PubMed ID: 38110312
[No Abstract] [Full Text] [Related]
7. [Evaluation of optimized sequential screening program of colorectal cancer in current China].
Li Q; Yu L; Xue F; Ma W; Yao K
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):995-1000. PubMed ID: 25582372
[TBL] [Abstract][Full Text] [Related]
8. Performance of a colorectal cancer screening protocol in an economically and medically underserved population.
Cai SR; Zhang SZ; Zhu HH; Huang YQ; Li QR; Ma XY; Yao KY; Zheng S
Cancer Prev Res (Phila); 2011 Oct; 4(10):1572-9. PubMed ID: 21952582
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary application of the Asia-Pacific colorectal screening score combined with the quantitative fecal occult blood in colorectal neoplasia screening].
Kang Q; Li N; Wang RF; Yang L; Jin P; Sheng JQ
Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3825-3828. PubMed ID: 34895425
[TBL] [Abstract][Full Text] [Related]
11. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
12. Performance value of high risk factors in colorectal cancer screening in China.
Meng W; Cai SR; Zhou L; Dong Q; Zheng S; Zhang SZ
World J Gastroenterol; 2009 Dec; 15(48):6111-6. PubMed ID: 20027686
[TBL] [Abstract][Full Text] [Related]
13. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
14. [The clinical value of multi-target stool fecal immunochemical test-DNA in early screening and diagnosis for colorectal cancer].
Li YL; Guan X; Dou LZ; Liu Y; Huang HY; Huang SK; Yang ZX; Wei BJ; Wu Y; Chen ZH; Wang GQ; Wang X; Cui W
Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(33):2607-2613. PubMed ID: 36058686
[No Abstract] [Full Text] [Related]
15. Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study.
Zhang M; Zhao L; Zhang Y; Jing H; Wei L; Li Z; Zhang H; Zhang Y; Zhu S; Zhang S; Zhang X
Front Oncol; 2022; 12():893183. PubMed ID: 35712520
[TBL] [Abstract][Full Text] [Related]
16. Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test.
He XX; Yuan SY; Li WB; Yang H; Ji W; Wang ZQ; Hao JY; Chen C; Chen WQ; Gao YX; Li LB; Cheng KL; Qian JM; Wang L; Li JN
BMC Gastroenterol; 2019 Dec; 19(1):226. PubMed ID: 31881948
[TBL] [Abstract][Full Text] [Related]
17. Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy.
Liao Y; Li S; Chen C; He X; Lin F; Wang J; Yang Z; Lan P
Gastroenterol Rep (Oxf); 2018 May; 6(2):132-136. PubMed ID: 29780602
[TBL] [Abstract][Full Text] [Related]
18. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
[TBL] [Abstract][Full Text] [Related]
19. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
20. Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens.
Berry E; Miller S; Koch M; Balasubramanian B; Argenbright K; Gupta S
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):647-653. PubMed ID: 31085338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
